These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Current trends in onychomycosis therapy: a literature review. Hecker D Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835 [TBL] [Abstract][Full Text] [Related]
23. Determination of susceptibility/resistance to antifungal drugs of Trichophyton mentagrophytes isolates by a macrodilution method. Barros ME; Hamdan JS Can J Microbiol; 2005 Nov; 51(11):983-7. PubMed ID: 16333338 [TBL] [Abstract][Full Text] [Related]
24. Successful treatment of proximal white subungual onychomycosis with oral terbinafine therapy. Aman S; Nadeem M; Haroon TS J Coll Physicians Surg Pak; 2008 Nov; 18(11):728-9. PubMed ID: 18983803 [TBL] [Abstract][Full Text] [Related]
25. Relapsing severe Trichophyton rubrum infections in an immunocompromised host: evidence of onychomycosis as a source of reinfection based on lectin typing. Gruseck E; Abeck D; Ring J Mycoses; 1993; 36(7-8):275-8. PubMed ID: 8114808 [TBL] [Abstract][Full Text] [Related]
26. Itraconazole in onychomycosis. Open and double-blind studies. Walsøe I; Stangerup M; Svejgaard E Acta Derm Venereol; 1990; 70(2):137-40. PubMed ID: 1969198 [TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and mycology of onychomycosis in autoimmune patients. Boonchai W; Kulthanan K; Maungprasat C; Suthipinittham P J Med Assoc Thai; 2003 Nov; 86(11):995-1000. PubMed ID: 14696780 [TBL] [Abstract][Full Text] [Related]
28. Onychomycosis in a diabetic patient due to Trichophyton gallinae. Poblete-Gutiérrez P; Abuzahra F; Becker F; Krause H; Merk HF; Frank J Mycoses; 2006 May; 49(3):254-7. PubMed ID: 16681822 [TBL] [Abstract][Full Text] [Related]
29. Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient. Balci DD; Cetin M Mycoses; 2008 Nov; 51(6):546-8. PubMed ID: 18422918 [TBL] [Abstract][Full Text] [Related]
30. [Epidemiology and management of onychomycosis in private dermatological practice in France]. Guibal F; Baran R; Duhard E; Feuilhade de Chauvin M Ann Dermatol Venereol; 2008; 135(8-9):561-6. PubMed ID: 18789289 [TBL] [Abstract][Full Text] [Related]
31. Onychomycosis caused by Fusarium solani in a woman with diabetes. Wu CY; Chen GS; Lan CC Clin Exp Dermatol; 2009 Dec; 34(8):e772-4. PubMed ID: 20055843 [TBL] [Abstract][Full Text] [Related]
32. Onychomycosis in eastern Nepal. Agarwalla A; Agrawal S; Khanal B Nepal Med Coll J; 2006 Dec; 8(4):215-9. PubMed ID: 17357634 [TBL] [Abstract][Full Text] [Related]
33. Ketoconazole in griseofulvin-resistant dermatophytosis. Robertson MH; Rich P; Parker F; Hanifin JM J Am Acad Dermatol; 1982 Feb; 6(2):224-9. PubMed ID: 6277999 [TBL] [Abstract][Full Text] [Related]
36. The use of systemic antimycotics in dermatotherapy. Niewerth M; Korting HC Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319 [TBL] [Abstract][Full Text] [Related]
37. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy. Del Rosso JQ J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929 [TBL] [Abstract][Full Text] [Related]
38. Onychomycosis caused by Scytalidium dimidiatum. Report of two cases. Review of the taxonomy of the synanamorph and anamorph forms of this coelomycete. Lacaz CS; Pereira AD; Heins-Vaccari EM; Cucé LC; Benatti C; Nunes RS; de Melo NT; de Freitas-Leite RS; Hernández-Arriagada GL Rev Inst Med Trop Sao Paulo; 1999; 41(5):319-23. PubMed ID: 10602547 [TBL] [Abstract][Full Text] [Related]